|
Fem-dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1® and RC-14® to colonize and protect the vaginal tract.
Clinical trials have shown that GR-1® and RC-14®:
fem-dophilus® is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency. The probiotic strains in fem-dophilus® are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.
![]() |
![]() |
Fem-dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1® and RC-14® to colonize and protect the vaginal tract.
Clinical trials have shown that GR-1® and RC-14®:
fem-dophilus® is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency. The probiotic strains in fem-dophilus® are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.
For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed, or take as directed by your qualified health care consultant.
Keep Refrigerated.
| Amount Per Serving | % Daily Value | |
| Total Probiotic Bacteria | 5 billion CFU | * |
| Lactobacillus rhamnosus GR-1® | ||
| Lactobacillus reuteri, RC-14® | ||
Contains: Dairy (casein, in trace amounts).